UY33618A - Analogos de buprenorfina - Google Patents
Analogos de buprenorfinaInfo
- Publication number
- UY33618A UY33618A UY0001033618A UY33618A UY33618A UY 33618 A UY33618 A UY 33618A UY 0001033618 A UY0001033618 A UY 0001033618A UY 33618 A UY33618 A UY 33618A UY 33618 A UY33618 A UY 33618A
- Authority
- UY
- Uruguay
- Prior art keywords
- buprenorfine
- analogs
- formula
- compounds
- buprenorphine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/09—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
- C07D489/10—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
- C07D489/12—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14 the bridge containing only two carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención está dirigida a los compuestos análogos de Buprenorfina de la Fórmula I, Fórmula IA o Fórmula IB que se enseñan a continuación, en los cuales R1, R2, R8, R3a, R3b, G, X, Z e Y son como se han definido en la descripción. Los compuestos de la invención son útiles para tratar el dolor, la constipación, y otras condiciones moduladas por la actividad de los receptores opioide y ORL-1.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38491210P | 2010-09-21 | 2010-09-21 | |
| US201161503674P | 2011-07-01 | 2011-07-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY33618A true UY33618A (es) | 2012-03-30 |
Family
ID=44903285
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY0001033618A UY33618A (es) | 2010-09-21 | 2011-09-20 | Analogos de buprenorfina |
Country Status (34)
| Country | Link |
|---|---|
| US (1) | US9221831B2 (es) |
| EP (1) | EP2619212B1 (es) |
| JP (2) | JP5977240B2 (es) |
| KR (2) | KR20150027315A (es) |
| CN (2) | CN103154000A (es) |
| AR (1) | AR083062A1 (es) |
| AU (1) | AU2011306644B2 (es) |
| CA (1) | CA2810356C (es) |
| CL (1) | CL2013000732A1 (es) |
| CO (1) | CO6690803A2 (es) |
| CR (1) | CR20130129A (es) |
| CY (1) | CY1117227T1 (es) |
| DK (1) | DK2619212T3 (es) |
| DO (1) | DOP2013000060A (es) |
| EA (1) | EA201390422A1 (es) |
| EC (1) | ECSP13012543A (es) |
| ES (1) | ES2566828T3 (es) |
| HR (1) | HRP20160281T1 (es) |
| HU (1) | HUE027195T2 (es) |
| ME (1) | ME02367B (es) |
| MX (1) | MX2013003354A (es) |
| NI (1) | NI201300032A (es) |
| NZ (1) | NZ609200A (es) |
| PE (1) | PE20140020A1 (es) |
| PH (1) | PH12013500530A1 (es) |
| PL (1) | PL2619212T3 (es) |
| RS (1) | RS54579B1 (es) |
| SG (1) | SG188300A1 (es) |
| SI (1) | SI2619212T1 (es) |
| SM (1) | SMT201600088B (es) |
| TW (2) | TW201422621A (es) |
| UY (1) | UY33618A (es) |
| WO (1) | WO2012038813A1 (es) |
| ZA (1) | ZA201301217B (es) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8852638B2 (en) | 2005-09-30 | 2014-10-07 | Durect Corporation | Sustained release small molecule drug formulation |
| CA2687979C (en) | 2007-05-25 | 2017-07-04 | Tolmar Therapeutics, Inc. | Sustained delivery formulations of risperidone compounds |
| US9272044B2 (en) | 2010-06-08 | 2016-03-01 | Indivior Uk Limited | Injectable flowable composition buprenorphine |
| GB2481017B (en) | 2010-06-08 | 2015-01-07 | Rb Pharmaceuticals Ltd | Microparticle buprenorphine suspension |
| US8846765B2 (en) | 2010-06-15 | 2014-09-30 | Gruenenthal Gmbh | Pharmaceutical combination |
| BR112013028886A2 (pt) | 2011-05-10 | 2016-08-09 | Gilead Sciences Inc | compostos heterocíclicos fundidos como moduladores dde canal de sódio |
| TW201837023A (zh) | 2011-07-01 | 2018-10-16 | 美商基利科學股份有限公司 | 作為離子通道調節劑之稠合雜環化合物 |
| NO3175985T3 (es) | 2011-07-01 | 2018-04-28 | ||
| EP2788358B1 (en) | 2011-12-08 | 2018-08-29 | Purdue Pharma LP | Quaternized buprenorphine analogs |
| US9315514B2 (en) * | 2012-08-27 | 2016-04-19 | Rhodes Technologies | 1,3-dioxanomorphides and 1,3-dioxanocodides |
| US10138207B2 (en) | 2012-11-09 | 2018-11-27 | Purdue Pharma, L.P. | Benzomorphan analogs and the use thereof |
| US9175000B2 (en) | 2012-12-07 | 2015-11-03 | Purdue Pharma L.P. | Buprenorphine analogs |
| US9056836B2 (en) | 2013-01-31 | 2015-06-16 | Purdue Pharma L.P. | Benzomorphan analogs and the use thereof |
| US8969358B2 (en) | 2013-03-15 | 2015-03-03 | Purdue Pharma L.P. | Buprenorphine analogs |
| WO2015097548A1 (en) * | 2013-12-26 | 2015-07-02 | Purdue Pharma L.P. | 7-beta-alkyl analogs of orvinols |
| WO2015097547A1 (en) | 2013-12-26 | 2015-07-02 | Purdue Pharma L.P. | 10-substituted morphinan hydantoins |
| EP3089982A4 (en) * | 2013-12-26 | 2017-09-27 | Purdue Pharma L.P. | 7-beta analogs of orvinols |
| EP3087079B1 (en) | 2013-12-26 | 2019-04-03 | Purdue Pharma LP | Opioid receptor modulating oxabicyclo[2.2.2]octane morphinans |
| US9656962B2 (en) | 2013-12-26 | 2017-05-23 | Purdue Pharma L.P. | Ring-contracted morphinans and the use thereof |
| WO2015099863A1 (en) | 2013-12-27 | 2015-07-02 | Purdue Pharma L.P. | 6-substituted and 7-substituted morphinan analogs and the use thereof |
| GB201404139D0 (en) | 2014-03-10 | 2014-04-23 | Rb Pharmaceuticals Ltd | Sustained release buprenorphine solution formulations |
| JP2017521373A (ja) | 2014-05-27 | 2017-08-03 | パーデュー、ファーマ、リミテッド、パートナーシップ | スピロ環モルフィナン及びその使用 |
| CA2951697A1 (en) | 2014-06-13 | 2015-12-17 | Purdue Pharma L.P. | Azamophinan derivatives and use thereof |
| MA41125A (fr) | 2014-12-05 | 2017-10-10 | Purdue Pharma Lp | Dérivés de 6.7-cyclomorphinane et leur utilisation |
| MX2018004835A (es) * | 2015-10-26 | 2018-08-01 | Orphomed Inc | Etilenglicol eter de buprenorfina. |
| EP3390355B1 (en) * | 2016-03-22 | 2022-12-28 | Helsinn Healthcare S.A. | Benzenesulfonyl-asymmetric ureas and medical uses thereof |
| WO2018125716A1 (en) | 2017-01-02 | 2018-07-05 | Purdue Pharma L.P. | Morphinan derivatives and use thereof |
| CA3063975A1 (en) | 2017-05-19 | 2018-11-22 | River Stone Biotech Aps | Preparation of buprenorphine |
| JP2021104932A (ja) * | 2018-03-30 | 2021-07-26 | 日本ケミファ株式会社 | モルヒナン誘導体の製造方法 |
| WO2024044179A1 (en) * | 2022-08-23 | 2024-02-29 | Virginia Commonwealth University | Multiple targeting opioid receptor ligands as novel analgesics with minimum abuse liability |
| WO2024211482A2 (en) * | 2023-04-04 | 2024-10-10 | Board Of Regents, The University Of Texas System | METHODS OF SYNTHESIZING 14-β-AMINOMORPHANS AND SALTS THEREOF |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1136764A (en) * | 1965-08-13 | 1968-12-18 | Reckitt & Sons Ltd | Derivatives of thebaine and oripavine |
| EP0990653B1 (en) | 1997-05-30 | 2004-09-15 | Banyu Pharmaceutical Co., Ltd. | 2-oxoimidazole derivatives |
| NZ507760A (en) | 1998-03-26 | 2002-10-25 | Japan Tobacco Inc | Amide derivatives and nociceptin antagonists |
| EP1368356A2 (en) | 2001-03-02 | 2003-12-10 | Euro-Celtique S.A. | N-but-3-enyl norbuprenorphine and its use as analgesic |
| US6740641B2 (en) | 2001-07-27 | 2004-05-25 | Euro-Celtique, S.A. | Sugar derivatives of hydromorphone, dihydromorphine and dihydromorphine, compositions thereof and uses for treating or preventing pain |
| AU2003272642B2 (en) | 2002-09-25 | 2009-07-09 | Euro-Celtique S.A. | N-substituted hydromorphones and the use thereof |
| ATE444296T1 (de) | 2002-10-25 | 2009-10-15 | Euro Celtique Sa | Analoga und prodrugs von buprenorphin |
| US7202259B2 (en) | 2002-11-18 | 2007-04-10 | Euro-Celtique S.A. | Therapeutic agents useful for treating pain |
| US6958398B1 (en) | 2002-12-30 | 2005-10-25 | Euro-Celtique S.A. | Methods for making thebaine or its acid salts |
| MX2009004822A (es) | 2006-11-01 | 2009-10-19 | Purdue Pharma Lp | Compuestos de fenilpropionamida y usos de los mismos. |
| GB2447014A (en) * | 2007-03-01 | 2008-09-03 | Reckitt Benckiser Healthcare | Analgesic composition comprising a specific ratio of buprenorphine and naltrexone |
| CN103275004A (zh) | 2007-11-30 | 2013-09-04 | 普渡制药公司 | 苯并吗啡烷化合物 |
| PT2326651E (pt) * | 2008-07-30 | 2014-02-12 | Purdue Pharma Lp | Análogos de buprenorfina |
| US9133131B2 (en) | 2011-11-15 | 2015-09-15 | Purdue Pharma L.P. | Pyrimidine diol amides as sodium channel blockers |
| EP2788358B1 (en) | 2011-12-08 | 2018-08-29 | Purdue Pharma LP | Quaternized buprenorphine analogs |
| CA2870605A1 (en) | 2012-05-11 | 2013-11-14 | Purdue Pharma L.P. | Benzomorphan compounds as opioid receptors modulators |
| US9315514B2 (en) | 2012-08-27 | 2016-04-19 | Rhodes Technologies | 1,3-dioxanomorphides and 1,3-dioxanocodides |
| US10138207B2 (en) | 2012-11-09 | 2018-11-27 | Purdue Pharma, L.P. | Benzomorphan analogs and the use thereof |
| US9175000B2 (en) | 2012-12-07 | 2015-11-03 | Purdue Pharma L.P. | Buprenorphine analogs |
| WO2014091295A1 (en) | 2012-12-14 | 2014-06-19 | Purdue Pharma L.P. | Pyridonemorphinan analogs and biological activity on opioid receptors |
| JP6163210B2 (ja) | 2012-12-14 | 2017-07-12 | パーデュー、ファーマ、リミテッド、パートナーシップ | 窒素含有モルフィナン誘導体およびその使用 |
| TW201434837A (zh) | 2012-12-14 | 2014-09-16 | Purdue Pharma Lp | 螺環嗎啡喃及其用途 |
| TW201441199A (zh) | 2012-12-28 | 2014-11-01 | Purdue Pharma Lp | 經取代之嗎啡喃類及其用途 |
| WO2014102587A1 (en) | 2012-12-28 | 2014-07-03 | Purdue Pharma L.P. | 7,8-cyclicmorphinan analogs |
| US9056836B2 (en) | 2013-01-31 | 2015-06-16 | Purdue Pharma L.P. | Benzomorphan analogs and the use thereof |
| US8969358B2 (en) | 2013-03-15 | 2015-03-03 | Purdue Pharma L.P. | Buprenorphine analogs |
| WO2015097548A1 (en) | 2013-12-26 | 2015-07-02 | Purdue Pharma L.P. | 7-beta-alkyl analogs of orvinols |
| WO2015097547A1 (en) | 2013-12-26 | 2015-07-02 | Purdue Pharma L.P. | 10-substituted morphinan hydantoins |
| EP3089982A4 (en) | 2013-12-26 | 2017-09-27 | Purdue Pharma L.P. | 7-beta analogs of orvinols |
| US9340542B2 (en) | 2013-12-26 | 2016-05-17 | Purdue Pharma L.P. | Propellane-based compounds and the use thereof |
| WO2015099863A1 (en) | 2013-12-27 | 2015-07-02 | Purdue Pharma L.P. | 6-substituted and 7-substituted morphinan analogs and the use thereof |
| US9902726B2 (en) | 2013-12-30 | 2018-02-27 | Purdue Pharma L.P. | Pyridone-sulfone morphinan analogs as opioid receptor ligands |
-
2011
- 2011-09-20 DK DK11776855.6T patent/DK2619212T3/en active
- 2011-09-20 EP EP11776855.6A patent/EP2619212B1/en active Active
- 2011-09-20 WO PCT/IB2011/002208 patent/WO2012038813A1/en not_active Ceased
- 2011-09-20 CN CN2011800450775A patent/CN103154000A/zh active Pending
- 2011-09-20 SG SG2013014113A patent/SG188300A1/en unknown
- 2011-09-20 KR KR20157004529A patent/KR20150027315A/ko not_active Withdrawn
- 2011-09-20 CA CA2810356A patent/CA2810356C/en not_active Expired - Fee Related
- 2011-09-20 ME MEP-2016-38A patent/ME02367B/me unknown
- 2011-09-20 JP JP2013529723A patent/JP5977240B2/ja not_active Expired - Fee Related
- 2011-09-20 SI SI201130750T patent/SI2619212T1/sl unknown
- 2011-09-20 PL PL11776855.6T patent/PL2619212T3/pl unknown
- 2011-09-20 RS RS20160119A patent/RS54579B1/sr unknown
- 2011-09-20 NZ NZ609200A patent/NZ609200A/en not_active IP Right Cessation
- 2011-09-20 PE PE2013000548A patent/PE20140020A1/es not_active Application Discontinuation
- 2011-09-20 MX MX2013003354A patent/MX2013003354A/es not_active Application Discontinuation
- 2011-09-20 PH PH1/2013/500530A patent/PH12013500530A1/en unknown
- 2011-09-20 US US13/825,241 patent/US9221831B2/en active Active
- 2011-09-20 HR HRP20160281TT patent/HRP20160281T1/hr unknown
- 2011-09-20 UY UY0001033618A patent/UY33618A/es unknown
- 2011-09-20 HU HUE11776855A patent/HUE027195T2/en unknown
- 2011-09-20 AR ARP110103431A patent/AR083062A1/es unknown
- 2011-09-20 CN CN201510733006.4A patent/CN105399751A/zh active Pending
- 2011-09-20 EA EA201390422A patent/EA201390422A1/ru unknown
- 2011-09-20 AU AU2011306644A patent/AU2011306644B2/en not_active Ceased
- 2011-09-20 KR KR1020137009943A patent/KR101630912B1/ko not_active Expired - Fee Related
- 2011-09-20 ES ES11776855.6T patent/ES2566828T3/es active Active
- 2011-09-21 TW TW102147960A patent/TW201422621A/zh unknown
- 2011-09-21 TW TW100133950A patent/TW201242968A/zh unknown
-
2013
- 2013-02-18 ZA ZA2013/01217A patent/ZA201301217B/en unknown
- 2013-03-18 CL CL2013000732A patent/CL2013000732A1/es unknown
- 2013-03-20 DO DO2013000060A patent/DOP2013000060A/es unknown
- 2013-03-20 NI NI201300032A patent/NI201300032A/es unknown
- 2013-03-21 CR CR20130129A patent/CR20130129A/es not_active Application Discontinuation
- 2013-04-05 EC ECSP13012543 patent/ECSP13012543A/es unknown
- 2013-04-18 CO CO13100225A patent/CO6690803A2/es unknown
-
2015
- 2015-11-19 JP JP2015226945A patent/JP2016102115A/ja not_active Withdrawn
-
2016
- 2016-03-04 CY CY20161100187T patent/CY1117227T1/el unknown
- 2016-03-24 SM SM201600088T patent/SMT201600088B/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY33618A (es) | Analogos de buprenorfina | |
| CR20130307A (es) | Composiciones y métodos para modular el fxr | |
| CR20120557A (es) | Compuestos químicos | |
| ECSP12012293A (es) | Ciertas amino-pirimidinas, composicioines de las mismas y métodos para el uso de los mismos | |
| CR20130671A (es) | Antagonistas de trpv4 | |
| CR20150359A (es) | Nuevos compuestos bicíclicos y su uso como agentes antibacterianos e inhibidores de b-lactamasa | |
| CR20150370A (es) | Compuestos antivirales | |
| CR20130295A (es) | Análogos de glucagón que presentan actividad de receptor de gip | |
| MX2019003738A (es) | Compuestos antivirales. | |
| ECSP12011902A (es) | Compuestos de espiropiperidina como antagonistas | |
| ZA201301902B (en) | Deuterated analogs of pridopidine useful as dopaminergic stabilizers | |
| DOP2015000076A (es) | Benzamidas | |
| WO2014140784A3 (en) | Buprenorphine analogs | |
| UY33497A (es) | Derivados de espiro-piperidina como moduladores s1p | |
| BR112014000306A2 (pt) | uma nova composição terapêutica contendo apomorfina como ingrediente ativo | |
| UY33323A (es) | Análogos de pirimidinilpiperidiniloxipiridinona como moduladores de gpr119 | |
| CR20130597A (es) | Isoxazolinas como agentes terapèuticos | |
| CO6761304A2 (es) | Nuevos compuestos de bezodioxol-piperazina | |
| CR20130654A (es) | 1-piperazino-3-fenil-indanos deuterados para el tratamiento de esquizofrenia | |
| GT201400169A (es) | Nuevos derivados de morofolinilo utiles como inhibidores de mogat-2 | |
| CR20120592A (es) | Intermedios de agomelatina y métodos de preparación de estos | |
| EP2830614A4 (en) | CYCLIC PRODRUGS FROM DUOCARMYCIN ANALOGUE | |
| TN2013000066A1 (en) | Buprenorphine analogs | |
| CR20130105A (es) | Derivados dihidrobenzoxatiazepinas, su preparación, composiciones farmacéuticas y utilización como moduladores de los receptores ampa | |
| BR112013004557A2 (pt) | novo processo. |